Average stock performance after each discretionary buy, measured at 1, 3 and 6 months. 25 buys in history.
Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Perspective Therapeutics, Inc. | 50,000 | reported | 02 Mar 2026 | tx 31+1,556,556 |
| Pharmasset Inc | 0 | reported | 12 Jan 2012 | tx 25+126,000−276,332.66 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 02 Mar 2026 | GRANT_AWARD | Perspective Therapeutics, Inc. | 50,000 | 0.00 USD | deriv |
| 12 Nov 2025 | PURCHASE | Perspective Therapeutics, Inc. | 9,498 | 2.10 USD | |
| 31 Mar 2025 | PURCHASE | Perspective Therapeutics, Inc. | 38,145 | 2.14 USD | |
| 28 Mar 2025 | PURCHASE | Perspective Therapeutics, Inc. | 22,192 | 2.27 USD | |
| 03 Mar 2025 | GRANT_AWARD | Perspective Therapeutics, Inc. | 50,000 | 0.00 USD | deriv |
| 25 Nov 2024 | PURCHASE | Perspective Therapeutics, Inc. | 3,647 | 3.62 USD | |
| 25 Nov 2024 | PURCHASE | Perspective Therapeutics, Inc. | 2,619 | 3.67 USD | |
| 20 Jun 2024 | GRANT_AWARD | Perspective Therapeutics, Inc. | 23,000 | 0.00 USD | deriv |
| 31 May 2024 | PURCHASE | Perspective Therapeutics, Inc. | 55,000 | 1.38 USD | |
| 29 May 2024 | PURCHASE | Perspective Therapeutics, Inc. | 11,375 | 1.32 USD | |
| 29 May 2024 | PURCHASE | Perspective Therapeutics, Inc. | 18,656 | 1.34 USD | |
| 30 Jan 2024 | PURCHASE | Perspective Therapeutics, Inc. | 42,879 | 0.72 USD | |
| 30 Jan 2024 | PURCHASE | Perspective Therapeutics, Inc. | 57,121 | 0.71 USD | |
| 30 Jan 2024 | PURCHASE | Perspective Therapeutics, Inc. | 5,127 | 0.71 USD | |
| 30 Jan 2024 | PURCHASE | Perspective Therapeutics, Inc. | 18,579 | 0.71 USD | |
| 30 Jan 2024 | PURCHASE | Perspective Therapeutics, Inc. | 3,500 | 0.70 USD | |
| 29 Jan 2024 | PURCHASE | Perspective Therapeutics, Inc. | 21,235 | 0.64 USD | |
| 26 Jan 2024 | PURCHASE | Perspective Therapeutics, Inc. | 8,513 | 0.59 USD | |
| 26 Jan 2024 | PURCHASE | Perspective Therapeutics, Inc. | 25,000 | 0.55 USD | |
| 26 Jan 2024 | PURCHASE | Perspective Therapeutics, Inc. | 50,000 | 0.54 USD | |
| 29 Jan 2024 | PURCHASE | Perspective Therapeutics, Inc. | 4,031 | 0.64 USD | |
| 26 Jan 2024 | PURCHASE | Perspective Therapeutics, Inc. | 12,250 | 0.61 USD | |
| 26 Jan 2024 | PURCHASE | Perspective Therapeutics, Inc. | 14,850 | 0.61 USD | |
| 25 Jan 2024 | PURCHASE | Perspective Therapeutics, Inc. | 22,134 | 0.49 USD | |
| 24 Jan 2024 | PURCHASE | Perspective Therapeutics, Inc. | 29,862 | 0.49 USD |